Advertisement

Racial Differences in the Prevalence and Outcomes of Atrial Fibrillation in Patients Hospitalized With Heart Failure

Published:February 16, 2016DOI:https://doi.org/10.1016/j.amjcard.2016.02.016
      Previous research has shown that roughly 15% to 30% of those with heart failure (HF) develop atrial fibrillation (AF). Although studies have shown variations in the incidence of AF in patients with HF, there has been no evidence of mortality differences by race. The purpose of this study was to assess AF prevalence and inhospital mortality in patients with HF among different racial groups in the United States. Using the National Inpatient Sample registry, the largest publicly available all-payer inpatient care database representing >95% of the US inpatient population, we analyzed subjects hospitalized with a primary diagnosis of HF from 2001 to 2011 (n = 11,485,673) using the International Classification of Diseases, Ninth Edition (ICD 9) codes 428.0-0.1, 428.20-0.23, 428.30-0.33, 428.40-0.43, and 428.9; patients with AF were identified using the ICD 9 code 427.31. We assessed prevalence and mortality among racial groups. Using logistic regression, we examined odds of mortality adjusted for demographics and co-morbidity using Elixhauser co-morbidity index. We also examined utilization of procedures by race. Of the 11,485,673 patients hospitalized with HF in our study, 3,939,129 (34%) had AF. Patients with HF and AF had greater inhospital mortality compared with those without AF (4.6% vs 3.3% respectively, p <0.0001). Additionally, black, Hispanic, Asian, and white patients with HF and AF had a 24%, 17%, 13%, and 6% higher mortality, respectively, than if they did not have AF. Among patients with HF and AF, minority racial groups had underutilization of catheter ablation and cardioversion compared with white patients. In conclusion, minority patients with HF and AF had a disproportionately higher risk of inpatient death compared with white patients with HF. We also found a significant underutilization of cardioversion and catheter ablation in minority racial groups compared with white patients.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to American Journal of Cardiology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • United States Census Bureau
        Facts for features: Hispanic heritage month 2014: Sept. 15-Oct. 15.
        2014 (Available at:) (Accessed on September 16, 2015)
        • United States Census Bureau
        Facts for features: Asian/Pacific heritage month: May 2014.
        2014 (Available at:) (Accessed on September 16, 2015)
        • United States Census Bureau
        Statistical abstract of the United States.
        2012 (Available at:) (Accessed on September 16, 2015)
        • Elixhauser A.
        • Steiner C.
        • Harris D.R.
        • Coffey R.M.
        Comorbidity measures for use with administrative data.
        Med Care. 1998; 36: 8-27
        • Southern D.A.
        • Quan H.
        • Ghali W.A.
        Comparison of the Elixhauser and Charlson/Deyo methods of comorbidity measurement in administrative data.
        Med Care. 2004; 42: 355-360
        • Alonso A.
        • Agarwal S.K.
        • Soliman E.Z.
        • Ambrose M.
        • Chamberlain A.M.
        • Prineas R.J.
        • Folsom A.R.
        Incidence of atrial fibrillation in whites and African-Americans: the Atherosclerosis Risk in Communities (ARIC) study.
        Am Heart J. 2009; 158: 111-117
        • Ruo B.
        • Capra A.M.
        • Jensvold N.G.
        • Go A.S.
        Racial variation in the prevalence of atrial fibrillation among patients with heart failure: the Epidemiology, Practice, Outcomes, and Costs of Heart Failure (EPOCH) study.
        J Am Coll Cardiol. 2004; 43: 429-435
        • Sun X.
        • Hill P.C.
        • Lowery R.
        • Lindsay J.
        • Boyce S.W.
        • Bafi A.S.
        • Garcia J.M.
        • Haile E.
        • Corso P.J.
        Comparison of frequency of atrial fibrillation after coronary artery bypass grafting in African Americans versus European Americans.
        Am J Cardiol. 2011; 108: 669-672
        • Jensen P.N.
        • Thacker E.L.
        • Dublin S.
        • Psaty B.M.
        • Heckbert S.R.
        Racial differences in the incidence of and risk factors for atrial fibrillation in older adults: the Cardiovascular Health Study.
        J Am Geriatr Soc. 2013; 61: 276-280
        • Lipworth L.
        • Okafor H.
        • Mumma M.T.
        • Edwards T.L.
        • Roden D.M.
        • Blot W.J.
        • Darbar D.
        Race-specific impact of atrial fibrillation risk factors in blacks and whites in the southern community cohort study.
        Am J Cardiol. 2012; 110: 1637-1642
        • Borzecki A.M.
        • Bridgers D.K.
        • Liebschutz J.M.
        • Kader B.
        • Kazis L.E.
        • Berlowitz D.R.
        Racial differences in the prevalence of atrial fibrillation among males.
        J Natl Med Assoc. 2008; 100: 237-245
        • Bush D.
        • Martin L.W.
        • Leman R.
        • Chandler M.
        • Haywood L.J.
        Atrial fibrillation among African Americans, Hispanics and Caucasians: clinical features and outcomes from the AFFIRM trial.
        J Natl Med Assoc. 2006; 98: 330-339
        • Rodriguez C.J.
        • Soliman E.Z.
        • Alonso A.
        • Swett K.
        • Okin P.M.
        • Goff Jr., D.C.
        • Heckbert S.R.
        Atrial fibrillation incidence and risk factors in relation to race-ethnicity and the population attributable fraction of atrial fibrillation risk factors: the Multi-Ethnic Study of Atherosclerosis.
        Ann Epidemiol. 2015; 25: 71-76
        • Thomas K.
        • Piccini J.
        • Liang L.
        • Fonarow G.
        • Yancy C.
        • Peterson E.
        • Hernandez A.
        Racial differences in the prevalence and outcomes of atrial fibrillation among patients hospitalized with heart failure.
        J Am Heart Assoc. 2013; 26: e000200
        • Aronow W.S.
        • Ahn C.
        • Kronzon I.
        Prognosis of congestive heart failure after prior myocardial infarction in older persons with atrial fibrillation versus sinus rhythm.
        Am J Cardiol. 2001; 87 (A8-9): 224-225
        • Rienstra M.
        • McManus D.D.
        • Benjamin E.J.
        Novel risk factors for atrial fibrillation: useful for risk prediction and clinical decision-making?.
        Circulation. 2012; 125: e941-e946
        • January C.T.
        • Wann L.S.
        • Alpert J.S.
        • Calkins H.
        • Cigarroa J.E.
        • Cleveland Jr., J.C.
        • Conti J.B.
        • Ellinor P.T.
        • Ezekowitz M.D.
        • Field M.E.
        • Murray K.T.
        • Sacco R.L.
        • Stevenson W.G.
        • Tchou P.J.
        • Tracy C.M.
        • Yancy C.W.
        2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the Heart Rhythm Society.
        Circulation. 2014; 130: 2071-2104
        • Lau C.P.
        • Gbadebo T.D.
        • Connolly S.J.
        • Van Gelder I.C.
        • Capucci A.
        • Gold M.R.
        • Israel C.W.
        • Morillo C.A.
        • Siu C.W.
        • Abe H.
        • Carlson M.
        • Tse H.F.
        • Hohnloser S.H.
        • Healey J.S.
        • ASSERT Investigators
        Ethnic differences in atrial fibrillation identified using implanted cardiac devices.
        J Cardiovasc Electrophysiol. 2013; 24: 381-387
        • Marcus G.M.
        • Alonso A.
        • Peralta C.A.
        • Lettre G.
        • Vittinghoff E.
        • Lubitz S.A.
        • Fox E.R.
        • Levitzky Y.S.
        • Mehra R.
        • Kerr K.F.
        • Deo R.
        • Sotoodehnia N.
        • Akylbekova M.
        • Ellinor P.T.
        • Paltoo D.N.
        • Soliman E.Z.
        • Benjamin E.J.
        • Heckbert S.R.
        • Candidate-Gene Association Resource (CARe) study
        European ancestry as a risk factor for atrial fibrillation in African Americans.
        Circulation. 2010; 122: 2009-2015
        • Taylor M.
        • Sun A.
        • Davis G.
        • Fiuzat M.
        • Liggett S.
        • Bristow M.
        Race, common genetic variation, and therapeutic response disparities in heart failure.
        JACC Heart Fail. 2014; 2: 561-572
        • Marcus G.M.
        • Olgin J.E.
        • Whooley M.
        • Vittinghoff E.
        • Stone K.L.
        • Mehra R.
        • Hulley S.B.
        • Schiller N.B.
        Racial differences in atrial fibrillation prevalence and left atrial size.
        Am J Med. 2010; 123: e1-e7
        • Lau C.P.
        • Tse H.F.
        • Siu C.W.
        • Gbadebo D.
        Atrial electrical and structural remodeling: implications for racial differences in atrial fibrillation.
        J Cardiovasc Electrophysiol. 2012; 23: S36-S40
        • Harris D.R.
        • Andrews R.
        • Elixhauser A.
        Racial and gender differences in use of procedures for black and white hospitalized adults.
        Ethn Dis. 1997; 7: 91-105
        • Ayanian J.Z.
        • Wiessman J.S.
        • Chasan-Taber S.
        • Epstein A.M.
        Quality of care by race and gender from congestive heart failure and pneumonia.
        Med Care. 1999; 37: 1260-1269
        • Ferguson J.A.
        • Tierney W.M.
        • Westmoreland G.R.
        • Mamlin L.A.
        • Segar D.S.
        • Eckert G.J.
        • Zhou X.H.
        • Martin D.K.
        • Weinberger M.
        Examination of racial differences in management of cardiovascular disease.
        J Am Coll Cardiol. 1997; 30: 1707-1713
        • Tamariz L.
        • Rodriguez A.
        • Palacio A.
        • Li H.
        • Myerburg R.
        Racial disparities in the use of catheter ablation for atrial fibrillation and flutter.
        Clin Cardiol. 2014; 37: 733-737
        • Freund K.M.
        • Jacobs A.K.
        • Pechacek J.A.
        • White H.F.
        • Ash A.S.
        Disparities by race, ethnicity, and sex in treating acute coronary syndromes.
        J Womens Health. 2012; 21: 126-132
        • Yancy C.W.
        • Jessup M.
        • Bozkurt B.
        • Butler J.
        • Casey D.E.
        • Drazner M.H.
        • Fonarow G.C.
        • Geraci S.A.
        • Horwich T.
        • Januzzi J.L.
        • Johnson M.R.
        • Kasper E.K.
        • Levy W.C.
        • Masoudi F.A.
        • Mcbride P.E.
        • McMurray J.J.
        • Mitchell J.E.
        • Peterson P.N.
        • Riegel B.
        • Sam F.
        • Stevenson L.W.
        • Tang W.H.
        • Tsai E.J.
        • Wilkoff B.L.
        2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines.
        J Am Coll Cardiol. 2013; 62: e147-e239
        • Trulock K.M.
        • Narayan S.M.
        • Piccini J.P.
        Rhythm control in heart failure patients with atrial fibrillation: contemporary challenges including the role of ablation.
        J Am Coll Cardiol. 2014; 7: 710-721